Biotech - Press Releases

Date	Title	Company
14-Jan-2020	Cedars-Sinai Joins Caris Life Sciences' Precision Oncology Alliance	Caris Life Sciences
14-Jan-2020	Caris Life Sciences Adds Premier Academic Brain Tumor Center to its Precision Oncology Alliance	Caris Life Sciences
13-Jan-2020	Michigan-based food manufacturer agrees to stop production after repeated food safety violations	U.S. Food and Drug Administration
13-Jan-2020	Amgen Announces Global Diagnostic Collaborations To Expand Molecular Testing For Patients With Non-Small Cell Lung Cancer	Amgen
13-Jan-2020	Codagenix Raises $20 Million in Series B Funding for Continued Development of RSV, Influenza and Oncolytic Virus Products	Codagenix, Inc.
13-Jan-2020	Bayer and Exscientia collaborate to leverage the potential of artificial intelligence in cardiovascular and oncology drug discovery	Exscientia
13-Jan-2020	SP Scientific launches the HT Series 3i Evaporators	SP Scientific
13-Jan-2020	Yposkesi selected to produce clinical and large-scale commercial material of micro-dystrophin for Genethon and Sarepta Therapeutics program	Yposkesi
13-Jan-2020	Calibre Scientific Acquires NeXtal Biotechnologies to Further Expand its Protein Portfolio	Calibre Scientific
13-Jan-2020	PharmaLex strengthens Healthcare Compliance services	PharmaLex GmbH
13-Jan-2020	Hansa Biopharma provides business update ahead of the JP Morgan Global Healthcare Conference	Hansa Biopharma
13-Jan-2020	Inflazome IP Portfolio Strengthened with Patents Granted in US and Europe	Inflazome
13-Jan-2020	Data monitoring committee approves initiation of expansion cohort in colorectal cancer patients	Faron Pharmaceuticals
13-Jan-2020	Exosomics implements NanoFCM’s NanoAnalyzer at its Siena facility to provide advanced extracellular vesicles-focused analytical services	NanoFCM
13-Jan-2020	Acquisition of Ashfield Pharmacovigilance Inc., a US pharmacovigilance services provider, from UDG Healthcare for $10 million	Ergomed plc
13-Jan-2020	LumiThera Closes 2nd Tranche of Series C Financing	LumiThera Inc.
13-Jan-2020	Actinium Pharmaceuticals Announces Iomab-ACT Program Gene Therapy Collaboration with UC Davis in Ongoing Clinical Trial for Patients with HIV-Related Lymphoma	Actinium Pharmaceuticals, Inc.
13-Jan-2020	Liminal BioSciences Outlines Corporate Priorities for 2020	Liminal BioSciences Inc.
13-Jan-2020	Oncolytics Biotech® Provides Recap of Key Opinion Leader Call Highlighting Pelareorep's Unique Ability to Activate the Immune System in Late Stage Multiple Myeloma	Oncolytics Biotech Inc.
13-Jan-2020	Introducing Generate Life Sciences(TM) - A First-Of-Its-Kind Company Focused On Helping Grow And Protect Healthy Families	Generate Life Sciences